These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 22753807)
1. Level of anticitrullinated peptide/protein antibody is not associated with lung diseases in rheumatoid arthritis. Jearn LH; Kim TY J Rheumatol; 2012 Jul; 39(7):1493-4. PubMed ID: 22753807 [No Abstract] [Full Text] [Related]
2. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. Zhu J; Zhou Y; Chen X; Li J J Rheumatol; 2014 Jul; 41(7):1282-9. PubMed ID: 24882837 [TBL] [Abstract][Full Text] [Related]
3. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Inui N; Enomoto N; Suda T; Kageyama Y; Watanabe H; Chida K Clin Biochem; 2008 Sep; 41(13):1074-7. PubMed ID: 18638466 [TBL] [Abstract][Full Text] [Related]
4. Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis? Zhao J; Liu X; Wang Z; Liu R; Li Z J Rheumatol; 2010 Dec; 37(12):2462-5. PubMed ID: 20952480 [TBL] [Abstract][Full Text] [Related]
5. Anti-cyclic citrullinated peptide antibody in early rheumatoid arthritis: comment on the editorial by Scott. van Venrooij WJ; van de Putte LB; van den Hoogen FH Arthritis Rheum; 2003 Mar; 48(3):857; author reply 857-8. PubMed ID: 12632446 [No Abstract] [Full Text] [Related]
6. Anti-CCP antibody in a patient with generalized discoid lupus erythematosus, vasculitis and acute interstitial lung disease but not rheumatoid arthritis. Lin YT; Tsai TH J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):826-8. PubMed ID: 24171815 [No Abstract] [Full Text] [Related]
7. Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry). Glace B; Gottenberg JE; Mariette X; Philippe R; Pereira B; Lequerré T; Berthelot JM; Dougados M; Toussirot E; Pham T; Allanore Y; Loeuille D; Euller-Ziegler L; Soubrier M Ann Rheum Dis; 2012 Aug; 71(8):1429-31. PubMed ID: 22504557 [No Abstract] [Full Text] [Related]
8. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis]. Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426 [TBL] [Abstract][Full Text] [Related]
9. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
10. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ioan-Facsinay A; el-Bannoudi H; Scherer HU; van der Woude D; Ménard HA; Lora M; Trouw LA; Huizinga TW; Toes RE Ann Rheum Dis; 2011 Jan; 70(1):188-93. PubMed ID: 20736390 [TBL] [Abstract][Full Text] [Related]
14. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. Candia L; Marquez J; Gonzalez C; Santos AM; Londoño J; Valle R; Zabaleta J; Yaqub Z; Espinoza LR J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808 [TBL] [Abstract][Full Text] [Related]
15. Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy. Damián-Abrego GN; Cabiedes J; Cabral AR Lupus; 2008 Apr; 17(4):300-4. PubMed ID: 18413411 [TBL] [Abstract][Full Text] [Related]
16. Q: Should I order an anti-CCP antibody test to diagnose rheumatoid arthritis? Bose N; Calabrese LH Cleve Clin J Med; 2012 Apr; 79(4):249-52. PubMed ID: 22473722 [No Abstract] [Full Text] [Related]
17. Synthesis of overlapping fibrin citrullinated peptides and their use for diagnosing rheumatoid arthritis. Pérez ML; Gómara MJ; Kasi D; Alonso A; Viñas O; Ercilla G; Sanmartí R; Haro I Chem Biol Drug Des; 2006 Oct; 68(4):194-200. PubMed ID: 17105483 [TBL] [Abstract][Full Text] [Related]
18. Are anti-cyclic citrullinated peptide antibodies pathogenic in rheumatoid arthritis? Holers VM Nat Clin Pract Rheumatol; 2006 Aug; 2(8):400-1. PubMed ID: 16932728 [No Abstract] [Full Text] [Related]
20. Evaluation of anti-CCP antibody for diagnosis of rheumatoid arthritis. Afzal N; Karim S; Mahmud TE; Sami W; Arif M; Abbas S Clin Lab; 2011; 57(11-12):895-9. PubMed ID: 22239019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]